1-10 of 10
Claudia M. Espitia
Close
Sort by
Journal Articles

Oncolytic Reovirus Is an Effective Treatment for Histone Deacetylase Inhibitor Resistant T-Cell Lymphoma

Shariful Islam, Claudia M Espitia, Ning Qu, MD PhD, Daniel Persky, MD, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2941.
https://doi.org/10.1182/blood-2018-99-119152
Published: 2018
Journal Articles

Oncolytic Reovirus Sensitizes Multiple Myeloma Cells to Anti-PD-L1 Therapy

Kevin R Kelly, MD PhD, Claudia M Espitia, Weiguo Zhao, Kaijin Wu, Valeria Visconte, PhD, Faiz Anwer, MD, Christine M Calton, PhD, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3137.
https://doi.org/10.1182/blood.V130.Suppl_1.3137.3137
Published: 2017
Journal Articles

A Novel Oncolytic Reovirus Immune Priming Strategy Dramatically Enhances the Efficacy of Anti-PD-L1 Antibody Therapy Against Multiple Myeloma

Kevin R. Kelly, MD PhD, Claudia M. Espitia, Weiguo Zhao, Valeria Visconte, PhD, Matt Coffey, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2016) 128 (22): 3960.
https://doi.org/10.1182/blood.V128.22.3960.3960
Published: 2016
Journal Articles

Antagonizing HDAC6 Activity: A New Strategy to Maximize the Anti-Myeloma Effects of BET Inhibition

Jennifer S. Carew, PhD, Claudia M. Espitia, Weiguo Zhao, Valeria Visconte, PhD, Kevin R. Kelly, MD PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2015) 126 (23): 3022.
https://doi.org/10.1182/blood.V126.23.3022.3022
Published: 2015
Journal Articles

Small Molecule Inhibition of SIRT Activity: A Novel Therapeutic Approach for Refractory Multiple Myeloma

Steffan T. Nawrocki, PhD, Claudia M. Espitia, Valeria Visconte, PhD, Yingchun Han, MD, Kevin R. Kelly, MD PhD, Jennifer S. Carew, PhD
Journal: Blood
Blood (2015) 126 (23): 1807.
https://doi.org/10.1182/blood.V126.23.1807.1807
Published: 2015
Journal Articles

The Novel Plk Inhibitor Volasertib Overcomes Cytarabine Resistance in Acute Myeloid Leukemia

Shuang Fu, MD, Kevin R. Kelly, MD, Claudia M. Espitia, MS, Yingchun Han, MD, Hetty E. Carraway, MD, Anjali S. Advani, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS, Nawrocki T. Steffan, PhD, Jennifer S. Carew, PhD
Journal: Blood
Blood (2014) 124 (21): 979.
https://doi.org/10.1182/blood.V124.21.979.979
Published: 2014
Journal Articles

Targeting HDAC6 Is a Novel Approach to Augment the Therapeutic Benefit of Bromodomain Inhibition in Multiple Myeloma

Jennifer S. Carew, PhD, Claudia M. Espitia, MS, Weiguo Zhao, MS, Kevin R. Kelly, MD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2014) 124 (21): 4760.
https://doi.org/10.1182/blood.V124.21.4760.4760
Published: 2014
Journal Articles

Small Molecule Inhibition of SIRT Activity: A Novel Therapeutic Approach for Acute Myeloid Leukemia

Steffan T Nawrocki, PhD, Claudia M Espitia, MS, Kevin R. Kelly, MD, William G. Bornmann, PhD, Jennifer S Carew, PhD
Journal: Blood
Blood (2011) 118 (21): 84.
https://doi.org/10.1182/blood.V118.21.84.84
Published: 2011
Journal Articles

The Investigational Multi-Targeted Kinase Inhibitor TAK-901 Antagonizes Acute Myeloid Leukemia Pathogenesis: Results of Preclinical Studies

Patrick Griffin, MD, Steffan T Nawrocki, PhD, Takashi Satou, PhD, Claudia M Espitia, MS, Kevin R. Kelly, MD, Maki Hasegawa, Swaminathan Padmanabhan, MBBS, MD, Angela Romanelli, Ron de Jong, PhD, Jennifer S Carew, PhD
Journal: Blood
Blood (2011) 118 (21): 581.
https://doi.org/10.1182/blood.V118.21.581.581
Published: 2011
Journal Articles

Targeting Pim Kinase Activity with the Novel Small Molecule Inhibitor SGI-1776 Significantly Augments the Efficacy of Cytarabine In Models of Acute Myeloid Leukemia

Kevin R Kelly, MD, Kelli Oberheu, B.S., Ernest Medina, B.S., Claudia M Espitia, MS, Devalingam Mahalingam, MD, PhD, Pietro Taverna, PhD, Gavin S. Choy, PharmD, MBA, Steffan T Nawrocki, PhD, Francis J. Giles, MB, MD, FRCPI, FRCPath, Jennifer S Carew, PhD
Journal: Blood
Blood (2010) 116 (21): 3253.
https://doi.org/10.1182/blood.V116.21.3253.3253
Published: 2010